[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Lamark et al., 2003 - Google Patents

Interaction codes within the family of mammalian Phox and Bem1p domain-containing proteins

Lamark et al., 2003

View HTML @Full View
Document ID
1381737906337915666
Author
Lamark T
Perander M
Outzen H
Kristiansen K
Øvervatn A
Michaelsen E
Bjørkøy G
Johansen T
Publication year
Publication venue
Journal of Biological Chemistry

External Links

Snippet

The Phox and Bem1p (PB1) domain constitutes a recently recognized protein-protein interaction domain found in the atypical protein kinase C (aPKC) isoenzymes, λ/ι-and ζPKC; members of mitogen-activated protein kinase (MAPK) modules like MEK5, MEKK2, and …
Continue reading at www.jbc.org (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)

Similar Documents

Publication Publication Date Title
Lamark et al. Interaction codes within the family of mammalian Phox and Bem1p domain-containing proteins
Noda et al. Molecular recognition in dimerization between PB1 domains
Delmolino et al. Multiple mechanisms regulate subcellular localization of human CDC6
Côté et al. Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity
Boggio et al. Targeting SUMO E1 to ubiquitin ligases: a viral strategy to counteract sumoylation
Lee et al. PRMT8, a new membrane-bound tissue-specific member of the protein arginine methyltransferase family
Sun et al. Interaction of human HSP22 (HSPB8) with other small heat shock proteins
Han et al. Association of focal adhesion kinase with Grb7 and its role in cell migration
Zhang et al. Negative regulation of toll-like receptor-mediated signaling by Tollip
Cao et al. A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase
Lee et al. JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors
Graham et al. Crystal structure of a β-catenin/Tcf complex
Kirsch et al. Direct binding of p130Cas to the guanine nucleotide exchange factor C3G
Koizumi et al. The subcellular localization of SF2/ASF is regulated by direct interaction with SR protein kinases (SRPKs)
Urquhart et al. Interaction of Pex5p, the type 1 peroxisome targeting signal receptor, with the peroxisomal membrane proteins Pex14p and Pex13p
Ren et al. The crystal structure of human adenylate kinase 6: An adenylate kinase localized to the cell nucleus
Cheng et al. Interaction of cyclin-dependent kinase 12/CrkRS with cyclin K1 is required for the phosphorylation of the C-terminal domain of RNA polymerase II
Vulsteke et al. Inhibition of spliceosome assembly by the cell cycle-regulated protein kinase MELK and involvement of splicing factor NIPP1
Hui et al. Mouse p56 blocks a distinct function of eukaryotic initiation factor 3 in translation initiation
Kim et al. Leucine zipper-mediated homodimerization of the p21-activated kinase-interacting factor, βPix: Implication for a role in cytoskeletal reorganization
Garrett et al. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop
Lu et al. The amino-terminal domain of the E subunit of vacuolar H+-ATPase (V-ATPase) interacts with the H subunit and is required for V-ATPase function
Fu et al. Activation of a nuclear Cdc2-related kinase within a mitogen-activated protein kinase-like TDY motif by autophosphorylation and cyclin-dependent protein kinase-activating kinase
Ranjan et al. A structural role for ATP in the formation and stability of the human origin recognition complex
Dierks et al. Actin cytoskeletal association of cytohesin-1 is regulated by specific phosphorylation of its carboxyl-terminal polybasic domain